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In somatic cells of female placental mammals, one X
chromosome is inactivated to minimize sex-related
dosage differences of X-encoded genes. Random X
chromosome inactivation (XCI) in the embryo is
a stochastic process, in which each X has an inde-
pendent probability to initiate XCI, triggered by the
nuclear concentration of one or more X-encoded
XCI-activators. Here, we identify the E3 ubiquitin
ligase RNF12 as an important XCI-activator. Addi-
tional copies of mouse Rnf12 or human RNF12 result
in initiation of XCI in male mouse ES cells and on
both X chromosomes in a substantial percentage of
female mouse ES cells. This activity is dependent
on an intact open reading frame of Rnf12 and corre-
lates with the transgenic expression level of RNF12.
Initiation of XCI is markedly reduced in differentiating
female heterozygous Rnf12+/ ES cells. These find-
ings provide evidence for a dose-dependent role of
RNF12 in the XCI counting and initiation process.
INTRODUCTION
In the mouse embryo proper, XCI is random with respect to the
parental origin of the inactivated X chromosome and is initiated
around 5 days post-coitum or upon ES cell differentiation
in vitro (Wutz and Gribnau, 2007). Initiation of XCI is marked by
transcriptional upregulation of the X-encoded Xist gene on the
future inactive X chromosome (Xi). Xist is a noncoding, spliced,
and polyadenylated RNA, which spreads over the Xi while
attracting protein complexes required for the silencing process
(Brockdorff et al., 1992; Brown et al., 1992; Zhao et al., 2008).
Tsix and Xite gene sequences overlap with the Xist gene but
are transcribed in the antisense direction and play an important
role in suppression of Xist transcription during the XCI process
(Lee and Lu, 1999; Ogawa and Lee, 2003).
XCI starts with counting of the number of X chromosomes and
selection of the future active X (Xa) and Xi. This process is
stochastic, and every X chromosome has an independentprobability to initiate XCI (Monkhorst et al., 2008). The probability
for any X chromosome to be inactivated increases with an
increased X to autosome ratio, suggesting involvement of an
X-encoded activator in the XCI counting process (Monkhorst
et al., 2008, 2009). Studies with cell lines and mice carrying
Xist and Tsix overexpression and knockout alleles have indicated
that these genes play a crucial role in determining the probability
to initiate XCI (Lee and Lu, 1999; Luikenhuis et al., 2001;
Marahrens et al., 1998; Nesterova et al., 2003). Tsix takes part
in setting up a threshold that has to be overcome by Xist in order
to initiate XCI. In counteracting Tsix, X-encoded XCI-activators
are responsible for dose-dependent activation of Xist expres-
sion, and autosomally encoded XCI-inhibitors act as dose-
dependent suppressors of Xist. XCI-activators might act either
through activation of Xist directly or by suppression of Tsix,
thereby lowering the threshold for initiation of XCI. Similarly,
XCI-inhibitors can be involved in direct suppression of Xist acti-
vation or exert their activity through an indirect mechanism such
as activation of Tsix expression.
During early embryonic development, or upon ES cell differen-
tiation, the concentration of the XCI-activators will be sufficient,
in female cells but not in male cells, to initiate XCI with a specific
probability per time frame. In this working hypothesis, inactiva-
tion of both X chromosomes in female cells is prevented by cis
inactivation of the genes encoding the XCI-activators and the
stochastic nature of XCI initiation. Nonetheless, the second
X chromosome will keep a probability to initiate XCI until the
XCI-activator concentration has dropped below the threshold
required to initiate XCI, after silencing of the XCI-activator
gene(s) in cis.
Recent findings indicate that CTCF, YY1, NANOG, SOX2, and
OCT4 exert activities as XCI-inhibitors, by taking part in suppres-
sion ofXist expression (Donohoe et al., 2007, 2009;Navarro et al.,
2008), and appear to involve Tsix-dependent and -independent
pathways. So far, X-linked genes encoding XCI-activators have
not been identified. Candidate regions on the X chromosome
involved in activation of XCI are delineated by different trans-
genes, several of them containing Xist and flanking sequences
that have been shown to induce ectopic XCI in male cells
(Herzing et al., 1997; Lee et al., 1996, 1999). However, this effect
was only obtainedwithmulticopy transgenes (Heard et al., 1999).
In addition, our finding that XCI is initiated in heterozygousCell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 999
Figure 1. BAC Contig Covering the X Inactivation Center
(A) Map showing part of the mouse X chromosome, the location of the BAC sequences used in this study, and the position of ms2 repeats within Xist. RNA-FISH
probes are indicated in green and red, and nonannotated genes in gray.
(B) RNA-FISHwith Xist (FITC) and Tsix probes (rhodamine red) on day 3 differentiated wild-type ES cells, showing cells with Xist clouds only detected with the Xist
probe (one marked with an arrow) and pinpoint signals detected with both Xist and Tsix probes (one marked with a star).
(C) RNA-FISH with an Xist probe (FITC) on day 3 differentiated male ES cells with an integration of BAC RP24-180B23, showing cells with Xist clouds (some
marked with arrows), and pinpoint signals (some marked with a star).
(D) RNA-FISH with Xist (FITC) and ms2 (rhodamine red) probes on day 3 differentiated 1.3 male ES cells with an integration of BAC RP24-180B23, showing that
Xist clouds are associated with autosomes, at a different location than the ms2-positive Tsix/Xist pinpoint signals (star).1000 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.
DXist-Tsix-Xite female cells (DXTX, Monkhorst et al., 2008) indi-
cates that Xist, Tsix, and Xite play redundant or marginal roles
in the XCI counting and initiation process and suggests that
important sequences regulating X chromosome counting and
initiation of XCI are located outside the deleted region. To identify
genes encoding XCI-activators we have performed a screen with
male and female BAC transgenic ES cell lines. From this, we have
obtained evidence that the X-encoded E3 ubiquitin ligase RNF12
is a dose-dependent factor involved in counting the number of
active X chromosomes present per mammalian cell nucleus,
which triggers initiation of random X chromosome inactivation.
RESULTS
A Screen to Identify XCI-Activator Genes
Previous studies have indicated that genes encoding the puta-
tive XCI-activators are most likely located within a region of
10 megabases (Mb) surrounding the Xist locus (Rastan, 1983;
Rastan and Robertson, 1985). To identify the XCI-activator
genes, we generated transgenic male and female ES cell lines
with stably integrated BAC transgenes covering part of this
10 Mb region. Our working hypothesis predicts that initiation
of XCI upon differentiation in transgenic male ES cells on the
single X, or initiation of XCI on both X chromosomes in a substan-
tial percentage of transgenic female ES cells, signifies the pres-
ence of additional copies of a gene encoding an XCI-activator on
the respective BAC.
Studies with mouse or human Xist/XIST transgenes in mouse
ES cells indicated that autosomal integration of these transgenes
results in activation of the endogenous Xist gene (Herzing et al.,
1997; Lee et al., 1999; Migeon et al., 2001). This suggests that
these transgenes include sequences encoding an XCI-activator.
We therefore started our screen with a BAC coveringmouse Xist,
excluding the transcription start sites of Tsix and Xite. BAC
RP24-180B23 was stably transfected into male ES cells. Clones
were expanded under neomycin selection and differentiated for
3 days before analysis. Besideswild-type ES cells, we alsomade
use of a male ES cell line 1.3, which contains 16 copies of anms2
repeat integrated in exon 7 of Xist (Figure 1A). This ms2 tag does
not interfere with XCI and allows discrimination between endog-
enous Xist-ms2 and transgenic Xist (Jonkers et al., 2008). BAC
integration and copy number were determined by DNA-FISH
and/or quantitative real-time PCR (qPCR). The percentage of
cells with accumulated Xist covering the Xi (Xist cloud) was
determined by RNA-FISH using an Xist cDNA probe, which
detects Xist and Tsix (in all FISH panels DNA is stained with
DAPI). The pinpoint signal detected with this Xist cDNA probe
is similar to the pinpoint signal obtained with a Tsix-specific
probe and represents basal Tsix/Xist transcription, which is
clearly distinguishable from an Xist-covered Xi (Figure 1B).
In most cell lines with an autosomal integration of the transgene,
we foundmale cells with single Xist clouds (Figure 1C; Table S2Aavailable online). RNA-FISH using Xist (FITC) and ms2 (rhoda-
mine red) probes performed on five different BAC transgenic
1.3 ES cell lines that were differentiated for 3 days revealed no
ms2-positive clouds (Figure 1D), indicating that the endogenous
Xist gene was never upregulated (which would lead to conver-
sion of the pinpoint signal to a cloud). This result was confirmed
using a RP23-338B22 BAC sequence covering all of Xist, Tsix,
and Xite (Table S2A). Autosomal Xist spreading in differentiating
male ES cells can be attributed to the absence of autosomal Tsix
sequences (RP24-180B23), or loss of autosomal Tsix expression
in cis due to truncation of one of the transgene copies or position
effects (RP23-338B22, Figure S1A). As a consequence of the
absence of Tsix expression in cis, a relatively low XCI-activator
concentration will be sufficient to induce autosomal Xist expres-
sion and spreading inmale cells, similar to findingswithmale Tsix
knockout ES cells (Luikenhuis et al., 2001; Sado et al., 2002;
Vigneau et al., 2006). Male and female mouse ES cell lines trans-
genic for BAC sequences CTD-2200N19 and CTD-2183M22
covering both human XIST and TSIX, or XIST alone (Figure 1F),
also did not show significant induction of endogenous Xist in
male cells (Figure 1E and Table S2A) or endogenous Xist accu-
mulation on both X chromosomes in female cells (Figures 1G,
S1B, and S1C). These results indicate that the tested regions
do not induce ectopic XCI in transgenic male and female cells
under the conditions that we used. Our findings contrast
previous claims that the Xist and Tsix regions are involved in
the XCI counting process (Herzing et al., 1997; Lee et al., 1996,
1999; Migeon et al., 2001) but may be explained by a difference
in transgene copy number or the number of clones that we
analyzed.
We continued our search for an XCI-activator gene by gener-
ating transgenic male ES lines with BACs covering Tsix including
a region 100 kb centromeric to Tsix (RP23-447O10), and BACs
covering a region 300 kb telomeric to Xist (CT7-474E4, RP24-
224E13, and RP23-100E1), and including two BACs (CT7-
474E4 and RP23-224E13) covering the Xpr region, which was
recently implicated in pairing and activation of Xist (Augui
et al., 2007). RNA-FISH analysis only revealed pinpoint Tsix/
Xist signals at day 3 of differentiation, indicating the absence of
XCI initiation on the wild-type X chromosome (Figures 1H and
1I and Table S2B). We also found no significant induction of
XCI on both X chromosomes in female BAC RP23-100E1,
CT7-474E4, and RP23-224E13 transgenic ES cells analyzed at
day 3 of differentiation (Table S2C). These results show that,
despite involvement of the Xpr region in X chromosome pairing
(Augui et al., 2007), additional transgenic copies of the Xpr region
do not interfere with the XCI counting and initiation process.
A Region on the X Chromosome Involved
in Activation of XCI
We continued our search for an XCI-activator gene and analyzed
transgenic cells with an integration of BAC RP24-240J16, which(E) RNA-FISH detecting mouse Xist (rhodamine red) and human XIST (FITC) on day 3 differentiated male cells transgenic for human CTD-2183M22 (Figure 1F).
(F) Map of human XIST and the location of the BAC sequences used to generate transgenic ES cell lines.
(G) RNA-FISH detecting murine Xist (rhodamine red) and human XIST (FITC) on day 3 differentiated transgenic female ES cells.
(H) Similar to (C), but with BACs RP23-447O10, CT7-474E4, and RP24-224E13.
(I) Percentage of CT7-474E4 male transgenic cell lines (6–24) with Xist clouds (green, BAC copies in gray, endogenous copies in black, n > 100 per cell line).Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 1001
Figure 2. Ectopic XCI in Transgenic Male and Female Embryonic Stem Cells
(A) RNA-FISH with an Xist probe (FITC) on day 3 differentiated ES cells with an integration of BAC RP24-240J16, showing male cells with Xist clouds (arrows) or
pinpoint signals (star) and female cells with two Xist clouds (arrows).
(B and C) Percentage of male cells with single Xist clouds (B) and female cells with two Xist clouds at day 3 of differentiation (C) and BAC copy number determined
by qPCR (BAC copies in gray, endogenous copies ofRnf12 in black; + indicates integration confirmed byDNA-FISH only; n > 100 per cell line). Female line 1-3 has
no BAC integration. ES cell lines that show a significant percentage of cells with Xist clouds compared to wild-type control lines are indicated with an asterisk
(nonoverlapping 95% confidence interval, p < 0.05).
(D) RNA/DNA-FISH detecting Xist (FITC) and an X chromosome-specific probe (rhodamine red) on day 3 differentiated 1.3 male ES cells.
(E) RNA-FISH detecting Xist (FITC) andms2 (rhodamine red) on day 3 differentiated female ES cells heterozygous for the Xist-ms2 tag, showing cells with two Xist
clouds, one marked by ms2. Cells with two Xist clouds only showed one Xist and one Xist-ms2 cloud (line 8, n = 46; line 9, n = 55).covers an area from 410 kb to 570 kb telomeric to Xist
(Figure 1A). Transgenic male ES cell lines were established using
three independent ES cell lines (F1 2-3, J1, and 1.3), and the BAC
integration was confirmed by qPCR and/or DNA-FISH (Figures
2B, 2C, S2A, and S2B). Interestingly, RNA-FISH analysis of
day 3 differentiated BAC transgenic ES cell lines showed several
lines with a significant number of cells with Xist clouds, which we
never observed in control male cell lines (95% confidence
interval, Figures 2A and 2B, Table S1, and Figure S2A). DNA/
RNA-FISH analysis detecting both the X chromosome and Xist
RNA confirmed that these male ES cells initiated XCI on the
single X chromosome (Figure 2D). In transgenic female cell lines
we also obtained an increased percentage of cells with two Xist
clouds (Figures 2A and 2C). RNA-FISH analysis on two indepen-
dent day 3 differentiated RP24-240J16 transgenic female lines,
heterozygous for the ms2 tag, showed that female cells with
two Xist clouds only had one ms2-positive cloud (Figure 2E).
Because aneuploidy would have resulted in a significant propor-
tion of cells with either two ms2-positive or two negative clouds,
this finding confirms that the transgenic female cells contained
two X chromosomes. Our results therefore suggest that BAC
RP24-240J16 harbors a gene encoding an XCI-activator.1002 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.Rnf12 Is an XCI-Activator
BAC RP24-240J16 encompasses Rnf12, which is ubiquitously
expressed in early mouse development, and two predicted
genes for which no expression data are available (Figure 1A).
To identify the sequences required for induction of XCI in male
cells, we fine-mapped the area using mouse BAC sequences
covering part of BAC RP24-240J16, thereby reducing the
minimal region required for ectopic XCI to 10 kb (Figure 3A and
Table S3). Expression analysis using total RNA of day 3 differen-
tiated female ES cells hybridized to a tiling array covering BAC
RP24-240J16 provided unequivocal data that Rnf12, which
encodes an E3 ubiquitin ligase, is the only transcribed sequence
within this region, and that the 10 kb region overlaps with the
promoter and exons 1 and 2 of Rnf12 (Figure 3B).
To establish a direct role of RNF12 in XCI, we disrupted the
open reading frame of Rnf12 by insertion of a neomycin/kana-
mycin resistance cassette in two orientations into exon 5 of
Rnf12. This mutation disrupts most of the open reading frame
but leaves the 10 kb minimal region required for ectopic XCI
intact. This allowed us to test whether the induction of XCI
is evoked either by a Rnf12-encoded protein or by a DNA
element within the 10 kb region (Figure 3C). Analysis of day 3
Figure 3. Rnf12 Encodes an XCI-Activator
(A) Position of BACs used for the fine-mapping, and their potential to stimulate XCI. BAC RP23-25P18, covering part of BAC RP24-240J16, was truncated (the
part shown as a solid line was found to be present using PCR analysis; not shown). The minimal region required for ectopic XCI is marked in blue.
(B) Tiling array expression analysis with total RNA of day 3 differentiated female ES cells (top panel, moving average in red, raw data in blue, y axis expression in
log2).
(C) Map of part of the X chromosome covered by BAC RP24-240J16 and the modified BAC RP24-240J16DRnf12 with a neomycin resistance cassette inserted in
two orientations (only the sense orientation is shown). Right panel shows confirmation of homologous recombination by PCR using the primer combination as
indicated.
(D) RNA-FISH detecting Xist (FITC) on day 3 differentiated BAC RP24-240J16 (left panels) and RP24-240J16DRnf12 (right panels).
(E) Summary of the results obtained with all RP24-240J16 and RP24-240J16DRnf12 cell lines. Avg copy nr. is average of copy number determined by qPCR of all
cloneswith extra BAC integrations. Pos. clones indicates the number of clones with extra BAC integrations versus all picked clones. A 95%nonoverlapping confi-
dence interval was used for scoring ES cell lines with a significant percentage of Xist clouds (p < 0.05), as determined by RNA-FISH of Xist. Not all positive clones
with BAC integrations could be analyzed.
(F) RT-PCR analysis with RNA isolated from day 3 differentiatedmale (129/Sv) and female (Cast/Ei 129/Sv) control cells andmale cells transiently transfectedwith
an Rnf12 expression construct (exp.). Analysis of NheI digested PCR products after gel electrophoresis indicates expression of transgenic Rnf12 (Cast/Ei).
(G) RT-qPCR analysis of Rnf12 and Xist expression in day 3 differentiated male cells transiently transfected with an Rnf12 expression construct (exp. 1 and 2).
Expression was compared to the expression level set at 1 in control cells (ctrl, t test: *p < 0.05, **p < 0.01). Error bars represent the standard deviation (SD).differentiated male ES cell lines with randomly integrated BAC
RP24-240J16DRnf12 (sense and antisense) transgenes contain-
ing the mutated Rnf12 gene revealed no significant induction of
XCI, in contrast to control transgenic male ES lines that showed
significant induction of XCI in most cell lines (Figures 3D and 3E
and Table S4A). This result was confirmed with transgenic 30D1
female ES cells, where only random integration of the unmodified
BAC RP24-240J16 resulted in an increased percentage of cells
with two Xi’s (Table S4B).
Transient expression of the Rnf12 cDNA might be sufficient to
induce XCI in male cells. To investigate this, we transiently trans-
fected male 1.3 ES cells with a Rnf12 expression vector at day 1
of differentiation, andRnf12 and Xist expression was determined
after 2 more days of differentiation. Xist RNA-FISH experiments
to test whether this transient expression ofRnf12 resulted in acti-
vation of XCI were inconclusive, most likely due to a low trans-
fection efficiency (<10%; measured by cotransfection of a GFP
expression vector). Using RT-PCR amplification of Rnf12
mRNA, followed by digestion with NheI, which digests a restric-
tion fragment length polymorphism (RFLP) present in the endog-
enous Rnf12 (129/Sv origin) PCR product but not in the trans-
genic Rnf12 (Cast/Ei origin) PCR product, we could show that
the transgenic Rnf12 gene is transcribed (Figure 3F). In agree-ment with this, RT-qPCR analysis indicated an increase in trans-
genic Rnf12 expression, and this correlated with increased Xist
expression, which was upregulated more than 2-fold in Rnf12-
transfected samples (Figure 3G). These results support the
view that Rnf12 is involved in Xist upregulation. The observed
upregulation of Xist was less pronounced than what would be
expected from the studies with BACs containing Rnf12, but
this is most likely due to the low transfection efficiency and cell
death of male 1.3 ES cells after initiation of XCI. In addition, in
the cells that have been transfected, the increased concentration
of RNF12may be lethal due to other functions of RNF12 that may
be compromised when there is an overdose of the protein. Inter-
estingly, Rnf12 BAC transgenic ES cells did not survive freeze
thawing. We think that extensive cell death may be initiated
through activation of RNF12 by the thawing procedure, possibly
resulting in ectopic XCI or misregulation of other processes.
In summary, fine-mapping and expression studies revealed
a 10 kb region on BAC RP24-240J16 to be required for ectopic
XCI. This region overlaps with exons 1 and 2 of Rnf12, which
is the only transcriptionally active gene covered by BAC
RP24-240J16. In addition, transgenes with a disrupted Rnf12
open reading frame do not induce ectopic XCI, whereas overex-
pression of Rnf12 results in induction of Xist expression. TheseCell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 1003
results provide strong evidence that Rnf12 encodes an XCI-
activator.
Conservation of RNF12 and Dose-Dependent Activation
of XCI by RNF12
Xist-mediated XCI is present in all eutherians, and previous
studies have indicated that Rnf12 is highly conserved among
mammals and other species (Bach et al., 1999). We wanted to
test whether human RNF12 can induce XCI in transgenic male
and female mouse ES cells. To this end, transgenic mouse ES
cells were generated containing human BAC CTD-2530H13
(Figure 4A), which covers an area that is homologous to the
region covered by mouse RP24-240J16 (Figure 1A) and shows
high sequence homology in the promoter and coding regions
of Rnf12/RNF12 (Figure 4B). Upon differentiation of several of
these CTD-2530H13 transgenic cells, XCI is induced in a signifi-
cant proportion of the male cells and on both X chromosomes in
an increased percentage of the female cells, suggesting that the
function of RNF12 in XCI in mouse and human is conserved
(Figures 4C, 4D, and 4E).
To further test whether RNF12 acts as a dose-dependent acti-
vator of XCI, we embryoid body (EB)-differentiated transgenic
BAC CTD-2530H13 ES cell lines for 3 days and used RT-qPCR
to determine the expression of mouse endogenous Rnf12 and
Xist and human transgenic RNF12. Comparison of Xist RNA-
FISH and RT-qPCR expression analysis showed a correlation
between transgenic RNF12 expression, Xist upregulation, and
activation of XCI on the single X in male cells (Pearson 0.77,
p < 0.001 and Pearson 0.67, p < 0.01, respectively, Figures 5A
Figure 4. The Action of Human RNF12 Is
Conserved in Mouse
(A) Schematic map of part of the human X chromo-
some and location of the BACs used for the
analysis.
(B) Alignment of mouse (RP24-240J16) and human
(CTD-2530H13) BAC sequences (bottom panel).
Shown is the region containing the Rnf12/RNF12
gene.
(C) RNA-FISH detecting Xist (FITC) on day 3 differ-
entiated CTD-2530H13 transgenic male ES cells
(left panels) and female ES cells (right panels).
(D and E) Quantification of RNA-FISH presented in
(C) for BAC transgenic male (D) and female (E) cell
lines and BAC copy number determined by qPCR
(gray, n > 100 per cell line). Day 3 differentiated ES
cell lines with a significant percentage of cells with
Xist clouds compared towild-type control lines are
indicated with an asterisk (nonoverlapping 95%
confidence interval, p < 0.05).
and 5B). The effect of transgenic RNF12
on Xist expression, determined by RT-
qPCR, is more pronounced in male than
in female cell lines because Xist is
normalized to the levels present in male
and female control cell lines, respectively
(Figures S4A and S4B). Some lines did
not show ectopic XCI despite expression
of transgenic RNF12 (clone nrs: _ 2–6, 2–21 [Figure 5B] and
\ 2–22 [Figure S4B]), whichmay be attributed to truncated trans-
genes giving rise to a nonfunctional RNA or to variegated expres-
sion through position effects resulting in only a few cells express-
ing the transgene at a relative high level. To compare the
expression level of RNF12 versus Rnf12, we amplified a length
polymorphism distinguishing RNF12 from Rnf12 by RT-PCR
(Figure 5C). Quantification of the relative intensity of RNF12
and Rnf12 confirmed a correlation between expression of trans-
genic RNF12, Xist upregulation, and XCI (Pearson 0.67, p < 0.01
and Pearson 0.58, p < 0.05, respectively). Our results also indi-
cate that transgenic expression is moderate, not reaching the
endogenous level, suggesting selection against cells that
express RNF12/Rnf12 at higher levels. We further investigated,
by combined RNA-FISH detecting Xist and RNF12, whether
expression of RNF12 correlated with Xist cloud formation. Anal-
ysis of two transgenic male and female cell lines indicated that
a single Xist cloud in male cells and two Xist clouds in female
cells were almost exclusively present in cells that showed an
RNF12 RNA-FISH signal (p < 0.0001, Z-test for proportion,
Figures 5D and 5E).
Although the function in XCI appears to be conserved, we do
not know whether the specific activities of mouse and human
RNF12 are equal. We therefore repeated the experiment shown
in Figure 5 but generated 1.3 male transgenic ES cells harboring
a BAC sequence covering the Mus. musculus mollosinus Rnf12
gene, which allowed us to use a RFLP (NheI) that discriminates
between endogenous and transgenic Rnf12 cDNA. Xist RNA-
FISH with day 3 differentiated transgenic ES cell lines containing1004 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.
Figure 5. RNF12 Is a Dose-Dependent Activator of XCI
(A) Expression analysis of male 1.3 cell lines targeted with the human CTD-2530H13 BAC containing RNF12. RT-qPCR was performed with primer sets for Xist
(green),Rnf12 (gray), andRNF12 (orange). All samples were normalized to beta-actin, and expression was compared to the average of wild-type cell lines 1.3 H13
1/13/20/24. Expression of human RNF12 was compared to expression of mouse Rnf12 of the control cell lines. Error bars represent SD.
(B) Table of male 1.3 cell lines targeted with the human CTD-2530H13 BAC containing RNF12. The relative copy number of the BAC integration, ranging from 
(no integration) to +++ (several copies). The RNA-FISH column represents percentage of cells with one Xist cloud (13Xist, *p < 0.05 based on a 95% confidence
interval, n is nr of cells counted).
(C) RT-PCR analysis detecting a length polymorphism distinguishing Rnf12 and RNF12. The relative expression of RNF12 compared to endogenous Rnf12 is
depicted below each lane.
(D) Xist-RNF12 RNA-FISH with day 3 differentiated BAC CTD-2530H13 transgenic male and female ES cell lines, detecting Xist clouds (rhodamine red) and
RNF12 transcription foci (FITC).
(E) Quantification of RNF12 transcription foci (RNF12), single (13Xist) or double (23Xist) Xist clouds, the percentage of cells with a single Xist cloud together with
an RNF12 signal in BAC CTD-2530H13 transgenic male ES cell lines (13Xist and RNF12), or two Xist clouds together with an RNF12 signal in BAC CTD-2530H13
transgenic female ES cell lines (2xXist and RNF12) at day 3 of differentiation (n = number of cells analyzed).at least one transgene copy showed induction of XCI in a signif-
icant proportion of cells for most ES cell lines (Figures S4D and
S4E). RT-PCR expression analysis confirmed that Mus. muscu-
lus mollosinus Rnf12 is expressed in the undifferentiated trans-
genic male cell lines that induce XCI, at 0.4- to 2.0-fold levels
compared to the expression level of one endogenous Rnf12
copy (Figure S4E). In addition, western blot analysis with anti-
RNF12, and anti-ACTIN as a control, confirmed elevated expres-
sion of RNF12 in day 1 differentiated transgenic male ES celllines compared to wild-type control cells (not all cell lines were
analyzed, Figure S4F). Expression of Rnf12 correlated with cells
that initiated XCI at day 3 of differentiation (Pearson 0.67, p <
0.01). Similar to our findings with CTD-2530H13 transgenic ES
cell lines, we only observed ES cell lines that showed moderate
expression of transgenic Rnf12.
The results obtained with transgenic ES cell lines harboring
human RNF12 andMus. musculus mollosinus Rnf12 transgenes
indicate that the function of RNF12 is most likely conserved fromCell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 1005
Figure 6. Expression Analysis of RNF12
(A) Western blot analysis detecting RNF12 (top panel)
and ACTIN (bottom panel) in female ES cells at
different time points in differentiation.
(B) Western blot analysis detecting RNF12 (top panel)
and ACTIN (bottom panel), comparing RNF12 expres-
sion in male and female undifferentiated (left panel),
day 2 differentiated ES cells (middle panel), and
MEFs (right panel).
(C) Immunocytochemistry on day 3 differentiated
female ES cells using an antibody detecting RNF12
(rhodamine red).
(D) RT-PCR expression analysis of Rnf12 with RNA
isolated from undifferentiated and day 7 differentiated
129/Sv Cast/Ei Tsix-stop ES cells, which exhibit
nonrandom XCI of the mutated 129/Sv X chromo-
some, using a NheI cleavage of the PCR product at
an RFLP present in the 129/Sv allele. The left two lanes
show control 129/Sv and Cast/Ei samples.
(E) RNA-FISH detecting Xist (FITC) on undifferentiated
BAC RP24-240J16 (left panels) transgenic female
ES cells.
(F) Table of female F1 2-1 cell lines targeted with BAC
RP24-240J16. The copy number of the BAC integra-
tion and the percentage of undifferentiated cells con-
taining one Xist cloud (13Xist) and day 3 differentiated
cells with two Xist clouds (23Xist) are depicted. The
column on the right shows the level of transgene
expression, determined by RFLP RT-PCR, relative to
one endogenous copy of Rnf12 in undifferentiated
ES cell lines. ES cell lines that show a significant
percentage of cells with Xist clouds compared to
wild-type control lines are indicated with an asterisk
(confidence interval 95%, p < 0.05).
(G) Western blot analysis detecting RNF12 (top
panel) and ACTIN (bottom panel) with nuclear extracts
of day 3 differentiated ES cell lines described in (F).human to mouse. Furthermore, expression of ectopic RNF12
positively correlates with expression of Xist and subsequent initi-
ation of XCI.
Endogenous RNF12 Expression Correlates with XCI
Rnf12 encodes an E3 ubiquitin ligase involved in the regulation of
LIM-homeodomain containing factors by targeting LIM-interact-
ingproteins LDB1andLDB1 for degradation (Bachet al., 1999). In
addition, RNF12 also appears to be involved in gene activation
and telomere length homeostasis, indicating that this multifac-
eted protein is involved in many important processes besides
XCI (Her and Chung, 2009; Johnsen et al., 2009). To play
a dose-dependent role in XCI, it is to be expected that, prior to
XCI, the RNF12 concentration is 2-fold higher in female cells
compared to male cells, and that expression of RNF12 is corre-
lated with the developmental time period when XCI is initiated.
In addition, to properly regulate XCI, Rnf12 expression should
be subject to XCI in order to ensure downregulation of RNF12,
therebypreventing initiationof XCI on the secondXchromosome.1006 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.To estimate the endogenous RNF12 expression in nuclear
extracts of male and female ES cells at different time points of
differentiation, we used western blot analysis with an antibody
detecting RNF12 and anti-ACTIN as a loading control. This anal-
ysis revealed that RNF12 is upregulated in female and male cells
around the time that XCI is initiated in female cells, after which
expression decreases in time (Figure 6A and data not shown).
Comparison of RNF12 expression in nuclear and cytoplasmic
extracts indicated that RNF12 is almost exclusively present in
the nucleus (data not shown). Immunocytochemistry also re-
vealed nuclear localization of RNF12 at day 3 of differentiation
(Figure 6C) and indicated that RNF12 did not localize to the Xi.
Comparison of RNF12 expression in Cast/Ei-129/Sv male and
female ES cell lines prior to XCI, and around the time that XCI
is initiated, confirms that RNF12 is more highly expressed in
female cells compared to male cells (Figure 6B). This difference
in RNF12 expression was absent in male and female mouse
embryonic fibroblasts (MEFs), suggesting that one copy of
Rnf12 is inactivated in female MEFs. Allele-specific RT-PCR
analysis with RNA of undifferentiated and day 7 differentiated
heterozygous Tsix mutant ES cells, which exclusively inactivate
the mutant 129/Sv X (Luikenhuis et al., 2001), indeed confirmed
that Rnf12 expression is subject to XCI (Figure 6D).
The above western blot analysis indicated that RNF12 is
already expressed prior to XCI, from which it can be suggested
that additional copies of Rnf12 may lead to XCI in undifferenti-
ated ES cells. We targeted F1 2-1 female cells with BAC RP24-
240J16 and picked and expanded neomycin-positive clones.
Undifferentiated ES cell lines with additional transgenic copies
of Rnf12, determined by qPCR, appeared indistinguishable
from wild-type undifferentiated ES cells. Undifferentiated and
day 3 differentiated ES cells were fixed and subjected to Xist
RNA-FISH analysis. We found that all the undifferentiated cell
lines with transgenic copies of Rnf12 showed Xist clouds, which
were not present in undifferentiated female control cells (Figures
6E and 6F). Interestingly, several of the cell lines with the highest
percentages of Xi’s in undifferentiated ES cells showed exten-
sive cell loss upon differentiation, with no or a few cells left to
analyze at day 3 of differentiation. The relative expression of
Rnf12 was estimated by RT-PCR amplifying an RFLP (NheI).
This analysis indicated increased expression of transgenic
Rnf12 in almost all undifferentiated transgenic ES cell lines
tested (Figure 6F), which correlated with Xist cloud formation
(Pearson 0.86, p < 0.01). Also the RNF12 protein levels in nuclear
extracts from cells at day 3 of differentiation were increased in
most transgenic ES cell lines compared to wild-type female cells
(Figure 6G), although lines 3–15 and 3–22 did not show an
increase in RNF12 expression, possibly due to cell loss of cells
overexpressing RNF12.
Taken together, these findings indicate that RNF12 is ex-
pressed in the time window of ES cell differentiation when XCI
is initiated, with a nuclear concentration of RNF12 that is higher
in female cells compared to male cells. Our results suggest that
the RNF12 concentration is well titrated to ensure a dose-depen-
dent role for RNF12 in activation of XCI. In agreement with this,
additional copies of Rnf12 can induce XCI in undifferentiated
female ES cells, indicating that an increase in the RNF12 concen-
tration is sufficient to trigger XCI.
XCI Is Reduced in Rnf12+/ Female Cells
RNF12 appears to be an important activator of X chromosome
counting and initiation of XCI, but it may not act as a single factor,
and the existence of one or more additional XCI-activators or
cofactors with RNF12-independent activity cannot be excluded.
To study this, we deleted Rnf12 from one X chromosome (129/
Sv) by targeting BAC RP24-240J16DRnf12 (sense and anti-
sense) to a polymorphic F1 2-1 female (Cast/Ei-129/SV) ES cell
line (Figure 7A). Correct targeting was confirmed by PCR ampli-
fication of a sequence containing a RFLP (NheI) that was
removed from the targeted allele (Figure 7B). Some 129/Sv
product is still detectable due to feeder cell (129/Sv) contamina-
tion. X chromosome copy number and origin were confirmed by
DNA-FISH (Figure S5), qPCR (not shown), and PCR amplification
of a sequence containing a RFLP (BrgI) in Xist (Figure 7B).
Western blot analysis with nuclear extracts from undifferentiated
wild-type and DRnf12+/ (sense) ES cells confirms that RNF12
expression is reduced in the heterozygous knockout ES cells(Figure 7C). Two heterozygous DRnf12+/ (sense and antisense)
ES cell lines were EB-differentiated, fixed at different time points,
and subjected to XistRNA-FISH.We found that initiation of XCI in
bothDRnf12+/ ES cell lines was severely reduced, bymore than
80%, at the start of differentiation (days 1–3) but recovered later
in the differentiation process (Figure 7D). EBs generated with
DRnf12+/ ES cells appeared smaller (data not shown), indi-
cating cell selection against cells that retain two active X chro-
mosomes and selection against cells that inactivated the wild-
type endogenous Rnf12, which would result in an RNF12 null
cell. Analysis of Xist expression using a length polymorphism
to distinguish cDNA originating from the 129/Sv or Cast/Ei allele
revealed that Xist is expressed from both alleles in the beginning
of the XCI process (Figure 7E), indicating that the probability to
initiate XCI is reduced for both X chromosomes in DRnf12+/
cells and is not caused by a cis effect of the Rnf12 mutation.
The F1 2-1 ES cells used in our studies show skewed XCI, with
a preference for Xist expression from, and inactivation of, the
129/Sv X chromosome, caused by the presence of two different
X-controlling elements (Xce’s) with different allelic properties. In
DRnf12+/ cells, from day 3 of differentiation onward, Xist is
almost exclusively expressed from the 129/Sv allele, suggesting
cell selection in favor of cells that inactivated the mutant Rnf12
allele. The presence of female DRnf12+/ cells that do initiate
XCI indicates that one or more additional X-encoded XCI-activa-
tors are involved in initiation of XCI. Nonetheless, the severe
reduction in cells that initiate XCI in the DRnf12+/ cells, and
our studies with Rnf12/RNF12 transgenic ES cells, both empha-
size an important role for RNF12 in XCI counting and initiation.
DISCUSSION
Herein, we have identified RNF12 as an X-encoded activator of
XCI in mouse embryonic stem (ES) cells. Additional copies of
mouse or human Rnf12/RNF12 result in an increased probability
to initiate XCI, resulting in XCI on the single X chromosome in
male cells and on both X chromosomes in female cells. The
action of RNF12 is dose dependent, and analysis of heterozy-
gous DRnf12+/ ES cells confirms a role for Rnf12 in XCI. At
the same time, our findings indicate that one or more additional
XCI-activators are involved in counting and initiation of XCI. Still,
it is evident that RNF12 plays a key role in control of X-chromo-
somal gene dosage between male and female cells and is there-
fore the first identified X-linked dose-dependent activator of XCI.
RNF12 Is a Potent Activator of XCI
Previous studies have indicated that ectopic XCI is initiated in
transgenic male cells containing additional copies of Xist/XIST
and flanking sequences (Herzing et al., 1997; Lee et al., 1996,
1999; Migeon et al., 2001). In the present analysis, these same
regions did not evoke ectopic XCI in transgenic male and female
cells. To try to explain this discrepancy, one could argue that
transgene copy number was different in the various studies,
and that the integration site and variegated transgene expres-
sion might be implicated. In addition, analysis of XCI at later
time points of the differentiation process might reveal induction
of XCI. The absence of initiation of ectopic XCI in our Xist/Tsix
transgenic cell lines indicates that additional sequences areCell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 1007
Figure 7. Generation and Analysis of Rnf12+/ Female ES Cells
(A) A map of part of the X chromosome and the BAC RP24-240J16DRnf12 targeting construct with a neomycin resistance cassette inserted in two orientations
(only sense orientation is shown), the targeted 129/Sv allele, and location of PCR primers used for genotyping.
(B) Left panel, RT-PCR with primers amplifying a RFLP (NheI) in the 129/Sv Rnf12 allele. Right panel, RT-PCR with a primer set amplifying a RFLP (BrgI) in the
129/Sv Xist allele.
(C) Western blot analysis detecting RNF12 (top panel) and ACTIN (bottom panel) in nuclear extracts from a wild-type female and DRnf12+/ ES cell line.
(D) Bar graph showing the percentage of wild-type and DRnf12+/ (sense and antisense) ES cells that initiated XCI, detected by Xist RNA-FISH, at different time
points of EB differentiation. Significant differences are marked with an asterisk (t test, * p < 0.05). Error bars represent SD.
(E) RT-PCR expression analysis of Xist originating form the129/Sv allele (top band) and the Cast/Ei allele (bottom band) with RNA isolated from days 2, 3, 4, and
7 differentiated wild-type and DRnf12+/ (sense) ES cells.
(F) Upon differentiation of the ES cells, the concentration of RNF12 and/or an unknown target or modifier of RNF12 increases, which potentiates the action of
RNF12. This leads to stochastic upregulation of Xist transcription (gray arrows, upregulation low, black arrows, upregulation high), resulting in a probability to
initiate XCI and accumulate along the X (+). Spreading of XistRNA leads to silencing ofRnf12 transcription in cis, resulting in a drop of the nuclear RNF12 concen-
tration, prohibiting inactivation of the second X. In male cells, the RNF12 concentration does not reach the threshold required to start this sequence of events.
(G) Rnf12-mediated activation of XCI could involve activation of Xist or suppression of Tsix through direct or indirect mechanisms (RNF12 in yellow). The action
of other putative XCI-activators (blue) could involve a similar mechanism as hypothesized for RNF12 (top panel) or could involve silencing of Tsix by Xist
RNA-mediated recruitment (bottom panel).1008 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.
required for proper Xic function, which is supported by our
previous finding that DXTX heterozygous ES cells still initiate
XCI (Monkhorst et al., 2008), and the finding that single copy
Xist/Tsix transgenes do not induce XCI on the endogenous
X chromosome (Heard et al., 1999). The Xpr region located
200 kb telomeric to Xist has been implicated in proposed pair-
ing of two X chromosomes (Augui et al., 2007) and activation of
Xist. However, our findings indicate that extra transgenic copies
of the Xpr region are not sufficient for initiation of ectopic XCI,
although this does not preclude a role for this region in the XCI
process. Regarding the present studies it should be noted that
almost all the male and female cell lines that we generated
with a BAC transgene containing Rnf12 resulted in XCI on the
single X chromosome in male cells (32 out of 38 cell lines) and
on both X chromosomes in female cells (17 out of 20 cell lines).
For most cell lines activation of XCI also correlated with expres-
sion of transgenic RNF12. From this, we feel that we can safely
conclude that RNF12 is a very potent activator of XCI.
The observation that the RP24-240J16 transgenic cells did not
initiate XCI on all X chromosomes can be explained by our finding
that RNF12 is not the only XCI-activator. Also, cells that inactivate
too many X chromosomes will be counterselected, possibly
masking the effect of Rnf12 on XCI, and expression of the trans-
genesmay have been variegated. More importantly, extra copies
ofRnf12/RNF12will lead to an increased probability to initiate XCI
in transgenic cells, which may never reach 100% in the time
interval required for one cell division, so that some cells can
always retain at least one Xa. Our expression analysis also indi-
cates that the expression level of transgenic Rnf12 is modest.
This suggests that higher expression levels are not tolerated
because this most likely results in extensive induction of XCI
already in undifferentiated ES cells and subsequent loss of the
transgenic cells. HigherRNF12 concentrationsmayalso compro-
mise cell viability due tomisregulation of other pathways in which
RNF12 takes part.We think thismay also explainwhy the effect of
transient expression of RNF12 on Xist induction is smaller than
what is obtained in low-copy transgenic ES cell lines because
theeffect of transient expressionofRNF12onXCImaybemasked
through extensive counterselection against transfected cells.
We found that XCI can be induced in undifferentiated female
transgenic ES cells expressing exogenous RNF12. This finding
could suggest that RNF12 overexpression induces ES cell differ-
entiation. However, undifferentiated wild-type and transgenic ES
cells appeared morphologically similar, and female ES cells with
two copies of Rnf12 have not been reported to be more differen-
tiated than male cells with one copy of Rnf12 (Lin et al., 2007).
Also, activation of XCI in Rnf12 transgenic male ES cells cannot
be explained by an effect of RNF12 on differentiation. It is there-
foremore likely thatRnf12 transgenic ES cells remain undifferen-
tiated, which implies that all other factors required for initiation of
XCI are already present in undifferentiated ES cells, although the
level of these other factorsmay increase upondifferentiation. Our
results also suggest that repression of Xist can be overcome by
increased expression ofRNF12, even in undifferentiated EScells.
Stochastic Initiation of XCI
A stochastic model for XCI predicts that every X chromosome
has an independent probability to be inactivated (Monkhorstet al., 2008). This contrasts with all other models that explain
counting and initiation of XCI through mutually exclusive mech-
anisms (Wutz and Gribnau, 2007). Our present findings support
a stochastic model for XCI and indicate that the probability to
initiate XCI is directed by a chance process that is dependent
on the nuclear concentration of different factors that promote
or suppress XCI.
As described and referenced in the Introduction, Xist and Tsix
knockout and overexpression studies have indicated that the
probability to initiate XCI is determined by the balance between
Xist and Tsix transcription, which is regulated by X-encoded XCI-
activators and autosomally encoded XCI-inhibitors. XCI-activa-
tors are involved in dose-dependent upregulation of Xist expres-
sion, whereas XCI-inhibitors are involved in suppression of Xist.
Protein expression analysis of differentiating female ES cells
indicates that RNF12 is expressed and upregulated around the
time that XCI is initiated. The nuclear concentration of RNF12
will reach a threshold, in female cells and not in male cells, that
is sufficient to upregulate Xist expression, either directly or
indirectly, to a point where it initiates XCI (Figure 7F). Other
XCI-activators may be present at a constant concentration or
reach a threshold in a similar fashion. The observed initiation
of XCI in undifferentiated female ES cells upon transgenic
RNF12 expression indicates that upregulation of RNF12 may
be required and sufficient to trigger XCI in female cells. However,
the predicted E3 ubiquitin ligase activity of RNF12 suggests that
expression or activity of additional factors, acting as substrate or
modifier of RNF12 action, are likely to be involved in XCI.
RNF12 or its downstream target(s) may act through activation
of Xist directly or indirectly by suppression of Tsix (Figure 7G).
Another possibility is that RNF12 is recruited by XistRNA in order
to silence Tsix, but RNF12 immunostaining did not show specific
accumulation of RNF12 anywhere in the nucleus, suggesting
that this is the least likely option. The evolutionary conservation
of RNF12 and activation of XCI in mouse ES cells by human
RNF12, taken together with the absence of an established role
for TSIX in human X inactivation, makes it likely that RNF12 is
involved in activation of Xist/XIST transcription. This is also sup-
ported by studies with Xist promoter transgenes, which showed
higher expression in female cells compared to male cells (Sun
et al., 2006).
After initiation of XCI, the XCI-activator genes will be silenced
in cis, providing a simple mechanism to decrease the concentra-
tion of the XCI-activators. Such a feedback mechanism will
prevent inactivation of the second X chromosome in female cells,
although the other X chromosome(s) still have a probability to
initiate XCI, in the time window in between initiation of XCI and
downregulation of the XCI-activator concentration at the protein
level. Previous studies have indicated that genes that are in close
proximity to Xist are more likely to be inactivated at an earlier
time point of development or ES cell differentiation than genes
located farther away. Close proximity of Rnf12 to Xistmay there-
fore facilitate a quick downregulation of RNF12 (Lin et al., 2007).
Re-evaluation of the data used for this study indicates that Rnf12
indeed belongs to the category of genes that are silenced early
during ES cell differentiation (Figure S6). Interestingly, Rnf12 is
also among the first genes to be downregulated in imprinted
XCI, which commences around the four- to eight-cell stage ofCell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc. 1009
embryonic development (Patrat et al., 2009), and silencing of
Rnf12 is strictly dependent on Xist (Kalantry et al., 2009). Also,
the stability of RNF12 has been reported to be much lower
than other nuclear proteins (Becker et al., 2003), which would
facilitate a rapid feed-back mechanism to prevent inactivation
of the second X chromosome.
Whether RNF12 is required for Xist expression after the Xi is
established remains to be determined. The observation that
Xist remains expressed on the Xi can be explained by silencing
of its negative regulator Tsix. On the Xi a lower XCI-activator
concentration would then be sufficient for sustained expression
of Xist. Following XCI, the reduced concentration of XCI-activa-
tors will be too low to induce XCI of the Xa, and its Xist gene is
silenced in a Tsix-dependent process involving Xist promoter-
specific DNA methylation and repressive histone modifications
(Ohhata et al., 2008; Sado et al., 2006; Sun et al., 2006).
More XCI-Activators Involved
Rnf12 is ubiquitously expressed in embryos around the onset of
XCI (Bach et al., 1999). One known target of RNF12 is LDB1,
which interacts with LIM-homeodomain transcription factors.
RNF12 is also involved in activation of estrogen receptor a (John-
sen et al., 2009) and degradation of a telomere-associating
protein, TRF1, with an effect on telomere length homeostasis
(Her and Chung, 2009). Hence, RNF12 likely acts as a regulator,
activator, or repressor, also outside the context of XCI, but none
of the known RNF12 partners from other pathways have been
implicated in XCI.
Analysis of DRnf12+/ cell lines indicates that Rnf12 is not the
only X-encoded XCI-activator regulating initiation of XCI. Similar
to Rnf12, these activators may be involved in activation of Xist
transcription or repression of Tsix through a direct mechanism
or by Xist RNA-mediated recruitment (Figure 7G). Studies on
other organisms provide clear examples of how dosage com-
pensation processes can be triggered by single master switch
genes: Sxl inDrosophila and Xol-1 inC. elegans. In both species,
these master switch genes are regulated by several X-encoded
numerator genes and autosomally encoded denominator
genes, suggesting that more than one numerator and denomi-
nator gene is required to suppress the noise in the system (Cline
and Meyer, 1996). For eutherians, a similar mechanism may
apply, with the Xist/Tsix locus representing the master switch
locus that is regulated by several XCI-activators and inhibitors
to count the number of X chromosomes and activate initiation
of XCI. Previous studies suggest that NANOG, SOX2, OCT4,
CTCF, and YY1 act as XCI-inhibitors. Depletion of these factors
results in increased Xist transcription indicating an involvement
in determining the threshold that has to be overcome for initiation
of XCI, either by direct repression of Xist or activation of Tsix
(Donohoe et al., 2007, 2009; Navarro et al., 2008). However,
the genes encoding the three pluripotency factors NANOG,
SOX2, and OCT4, and also the genes encoding CTCF and
YY1, are all located on autosomes and are most likely not differ-
entially expressed between male and female cells. Therefore,
despite a clear involvement in XCI, these genes are not likely
candidates to direct the XCI counting process. In contrast, the
X-chromosomal Rnf12 gene can be readily envisaged to encode
a protein that acts as a numerator to discriminate between1010 Cell 139, 999–1011, November 25, 2009 ª2009 Elsevier Inc.chromosomally male and female cells in relation to XCI. RNF12
represents the first identified XCI-activator, involved in deter-
mining the probability to initiate XCI. Identification and charac-
terization of the direct target or modifier of RNF12, and other
genes encoding XCI-activators, will be the next step to further




Transgenic ES cell lines were generated using wild-type male J1 (129/Sv),
F1 2-3 (129/Sv-Cast/Ei) ES lines, or a wild-type female line F1 2-1 (129/Sv-
Cast/Ei). For determination of the origin of Xist a male line 1.3 and female
line 30D1 were used, which both contain one Xist allele with 16 ms2 repeats
integrated in exon 7 (Jonkers et al., 2008). ES cells were grown and differenti-
ated as described (Monkhorst et al., 2008). Rnf12 transgenic ES cells did not
survive freeze thawing and were made fresh prior to analysis. All wild-type cell
lines and modified BACs will be made available on request.
Transient Expression of Rnf12
Cast/Ei Rnf12 cDNA was PCR amplified and cloned into pEGFP-N1 (Clon-
tech), replacing the EGFP coding sequence. Male 1.3 ES cells were differenti-
ated for 1 day and then transfected with or without the Rnf12 expression
construct using lipofectamine (Invitrogen). The cells were cotransfected with
a GFP expression construct for determining the transfection efficiency. The
cells were harvested at day 3 of differentiation.
RNA and RNA/DNA-FISH
RNA-FISH and RNA/DNA-FISH were performed as described (Jonkers et al.,
2008; Monkhorst et al., 2008). For detection of the region surrounding Xist
(Xic probe) a cocktail of biotin-labeled BAC sequences was used (CT7-
474E4, CT7-45N16, CT7-155J2, and CT7-211B4). The Tsix RNA-FISH probe
was a 5 kb SacII-SalI fragment (134071-139156 in AJ421479).
SUPPLEMENTAL DATA
Supplemental Data contain BAC engineering procedures, procedures for
BAC copy number determination and expression analysis, statistical proce-
dures, six figures, and four tables and can be found with this article online at
http://www.cell.com/supplemental/S0092-8674(09)01360-9.
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